Dietary supplements and fatigue in patients with breast cancer: a systematic review Paula Tâmara Vieira Teixeira PereiraAndréa Dias ReisJoão Batista Santos Garcia Review 18 June 2018 Pages: 515 - 526
Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings David S. BarretoEmily L. SedgwickAna P. Benveniste Review 03 July 2018 Pages: 527 - 534
Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis Jiayu WangBinghe XuXuelian Chen Review 04 July 2018 Pages: 535 - 544
Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence Fernando A. AngaritaMaryam ElmiNicole J. Look Hong Review 04 July 2018 Pages: 545 - 564
Breast cancer and its impact in male transsexuals Dejan NikolićMiroslav GranićMiroslav Djordjević Review 05 July 2018 Pages: 565 - 569
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment Emanuel C. A. BauerFabienne Schochterthe SUCCESS Study Group Preclinical study 21 June 2018 Pages: 571 - 580
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells Audrey BertheMarie ZaffinoStéphane Flament Preclinical study 03 July 2018 Pages: 581 - 591
Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer Nashwa KabilRecep BayraktarBulent Ozpolat Preclinical study 03 July 2018 Pages: 593 - 605
Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review Andrew RobinsonOsama SouiedMark Clemons Preclinical study 04 July 2018 Pages: 607 - 620
A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge Kristin E. RojasDonna-Marie ManassehPatrick I. Borgen Clinical trial 18 June 2018 Pages: 621 - 626
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling M. MartÃnJ. C. de la Torre-MonteroA. Lluch Clinical trial Open access 19 June 2018 Pages: 627 - 634
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling M. MartÃnJ. C. de la Torre-MonteroA. Lluch Correction 16 July 2018 Pages: 635 - 636
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases Amanda E. D. Van SwearingenMarni B. SiegelCarey K. Anders Clinical trial 25 June 2018 Pages: 637 - 648
Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy Dong-Yun LeeYeon Hee ParkDooSeok Choi Clinical trial 25 June 2018 Pages: 649 - 656
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy Yihan SunJae Hyun KimDaniel L. Hertz Clinical trial 26 June 2018 Pages: 657 - 666
Availability of prior mammograms affects incomplete report rates in mobile screening mammography Marilyn A. RoubidouxPeggy Shih-Pei WuAnnette I. Joe Clinical trial 28 June 2018 Pages: 667 - 673
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03 Yasuaki SagaraMasahiro TakadaMasakazu Toi Clinical trial 03 July 2018 Pages: 675 - 683
Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial Bertha Andrade CoelhoSara de Pinho Cunha PaivaAgnaldo Lopes da Silva Filho Clinical trial 05 July 2018 Pages: 685 - 692
Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED) Rosa LuraschiRoberta LazzariFederica Cattani Clinical trial 05 July 2018 Pages: 693 - 699
CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy Laura E. JansenWendy A. TeftRichard B. Kim Clinical trial 06 July 2018 Pages: 701 - 708
Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study K. J. JerzakJ. G. CockburnA. Bane Epidemiology 18 June 2018 Pages: 709 - 717
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype Yoon-Sim YapPrabhakaran MunusamyAnn S. G. Lee Epidemiology 21 June 2018 Pages: 719 - 735
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort Ji-Yeon KimJi Eun LimYoung-Hyuck Im Epidemiology 21 June 2018 Pages: 737 - 745
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer Meghan BrennanPaul GassPeter A. Fasching Epidemiology 27 June 2018 Pages: 747 - 758
Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women Julie S. BediRachel M. MayoKaryn Jones Epidemiology 03 July 2018 Pages: 759 - 765
Screening mammography: benefit of double reading by breast density My von Euler-ChelpinMartin LillholmElsebeth Lynge Epidemiology Open access 04 July 2018 Pages: 767 - 776
Estrogen-receptor status and risk of contralateral breast cancer following DCIS Natasha K. StoutAngel M. CroninRinaa S. Punglia Brief Report 26 June 2018 Pages: 777 - 781
